Impact of the Revised EU Clinical Trial Regulation

Posted 24 April 2017 By Siegfried Schmitt, Federico Bonacci, MD, Daniela Lisini, PhD, Dr. Viviana Mascilongo

placeholder+image Clinical Trial Regulation EU No 536/2014 will come into effect in 2018. This article reports on aspects of the revised regulation and evaluates its potential impact on clinical trials conducted to assess medicinal products for human use. It discusses changes impacting the critical role of the Ethics Committees in the approval process for clinical trials as well as the planned, centralized data reporting channel, referred to as "the portal." While revisions to the regulation are still underway, readers will benefit from the assessment of its current status and anticipated developments.

Share this article:

Categories: Biologics and biotechnology, Drugs, Clinical, Features, Europe, EMA, EC

Tags: Clinical Trial Regulation, EU No 536/2014

Regulatory Exchange: Latest Updates From the Community